July 3, 2024
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Human Genome Research Institute (NHGRI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
This notice extends the expiration date for PAR-21-313: Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional).
Expiration Date: New Date January 8, 2025 (Previous Expiration Date September 08, 2024).
As part of the extension, additional application due date(s) have been added to the key dates section of the opportunity(ies) as follows:
Previously read:
The following table includes NIH standard due dates marked with an asterisk.
Application Due Dates | Review and Award Cycles | ||||
---|---|---|---|---|---|
New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
October 16, 2021 * | November 16, 2021 * | January 07, 2022 * | March 2022 | May 2022 | July 2022 |
February 16, 2022 * | March 16, 2022 * | May 07, 2022 * | July 2022 | October 2022 | December 2022 |
June 16, 2022 * | July 16, 2022 * | September 07, 2022 * | November 2022 | January 2023 | April 2023 |
October 16, 2022 * | November 16, 2022 * | January 07, 2023 * | March 2023 | May 2023 | July 2023 |
February 16, 2023 * | March 16, 2023 * | May 07, 2023 * | July 2023 | October 2023 | December 2023 |
June 16, 2023 * | July 16, 2023 * | September 07, 2023 * | November 2023 | January 2024 | April 2024 |
October 16, 2023 * | November 16, 2023 * | January 07, 2024 * | March 2024 | May 2024 | July 2024 |
February 16, 2024 * | March 16, 2024 * | May 07, 2024 * | July 2024 | October 2024 | December 2024 |
June 16, 2024 * | July 16, 2024 * | September 07, 2024 * | November 2024 | January 2025 | April 2025 |
The NOFO is modified to read (changes in bold Italics):
The following table includes NIH standard due dates marked with an asterisk.
Application Due Dates | Review and Award Cycles | ||||
---|---|---|---|---|---|
New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
October 16, 2021 * | November 16, 2021 * | January 07, 2022 * | March 2022 | May 2022 | July 2022 |
February 16, 2022 * | March 16, 2022 * | May 07, 2022 * | July 2022 | October 2022 | December 2022 |
June 16, 2022 * | July 16, 2022 * | September 07, 2022 * | November 2022 | January 2023 | April 2023 |
October 16, 2022 * | November 16, 2022 * | January 07, 2023 * | March 2023 | May 2023 | July 2023 |
February 16, 2023 * | March 16, 2023 * | May 07, 2023 * | July 2023 | October 2023 | December 2023 |
June 16, 2023 * | July 16, 2023 * | September 07, 2023 * | November 2023 | January 2024 | April 2024 |
October 16, 2023 * | November 16, 2023 * | January 07, 2024 * | March 2024 | May 2024 | July 2024 |
February 16, 2024 * | March 16, 2024 * | May 07, 2024 * | July 2024 | October 2024 | December 2024 |
June 16, 2024 * | July 16, 2024 * | September 07, 2024 * | November 2024 | January 2025 | April 2025 |
October 16, 2024* | November 16, 2024* | January 7, 2025* | March 2025 | May 2025 | July 2025 |
All other aspects of this NOFO remain the same.
Please direct all inquiries to:
Albert Avila, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-496-8804
Email: [email protected]
Katrina J. Serrano, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-480-7855
Email: [email protected]
Michael J Pazin, Ph.D.
National Human Genome Research Institute (NHGRI)
Phone: 301-496-7531
E-mail: [email protected]